{"component": "definition", "props": {"groups": [{"snippet": "means the Program Know-How and the Program Patent Rights.", "size": 10, "snippet_links": [{"key": "the-program", "type": "clause", "offset": [6, 17]}, {"key": "program-patent-rights", "type": "clause", "offset": [35, 56]}], "samples": [{"hash": "hDA4WfVCFIe", "uri": "/contracts/hDA4WfVCFIe#program-ip", "label": "Development Collaboration and Exclusive License Agreement (Molecular Templates, Inc.)", "score": 29.8651599884, "published": true}, {"hash": "lMQKAYAgBVc", "uri": "/contracts/lMQKAYAgBVc#program-ip", "label": "Multi Target Collaboration and License Agreement (Molecular Templates, Inc.)", "score": 28.7919235229, "published": true}, {"hash": "39usDv12blq", "uri": "/contracts/39usDv12blq#program-ip", "label": "Multi Target Collaboration and License Agreement (Molecular Templates, Inc.)", "score": 28.597536087, "published": true}], "hash": "8425124c948115ca53b2d1be41ef4a0d", "id": 1}, {"snippet": "means Know-How and Materials, plus all Patents arising therefrom, created or conceived in connection with the activities performed pursuant to the Research Collaboration (whether solely by one party or jointly by the parties, in each case optionally with their Affiliates or any licensees, sublicensees, subcontractors or any other Third Parties or any employees, consultants or agents of any of the foregoing).", "size": 7, "snippet_links": [{"key": "all-patents", "type": "clause", "offset": [35, 46]}, {"key": "in-connection-with", "type": "clause", "offset": [87, 105]}, {"key": "the-activities", "type": "clause", "offset": [106, 120]}, {"key": "the-research-collaboration", "type": "clause", "offset": [143, 169]}, {"key": "one-party", "type": "definition", "offset": [189, 198]}, {"key": "jointly-by-the-parties", "type": "clause", "offset": [202, 224]}, {"key": "each-case", "type": "definition", "offset": [229, 238]}, {"key": "other-third-parties", "type": "clause", "offset": [326, 345]}, {"key": "the-foregoing", "type": "definition", "offset": [396, 409]}], "samples": [{"hash": "jxGFifK8dNk", "uri": "/contracts/jxGFifK8dNk#program-ip", "label": "Collaboration and License Agreement (Ra Pharmaceuticals, Inc.)", "score": 27.7816562653, "published": true}, {"hash": "8cY3jnSQFUx", "uri": "/contracts/8cY3jnSQFUx#program-ip", "label": "Collaboration and License Agreement (Ra Pharmaceuticals, Inc.)", "score": 27.7460651398, "published": true}, {"hash": "ieKIAm2geiY", "uri": "/contracts/ieKIAm2geiY#program-ip", "label": "Collaboration and License Agreement (Ra Pharmaceuticals, Inc.)", "score": 27.6255989075, "published": true}], "hash": "7aa9c9401b5d5cfdd6e95be8d088c282", "id": 2}, {"snippet": "means, collectively:", "size": 6, "snippet_links": [], "samples": [{"hash": "1PRlwCf6H1w", "uri": "/contracts/1PRlwCf6H1w#program-ip", "label": "Master Collaboration Agreement", "score": 31.3408622742, "published": true}, {"hash": "jyCPZUGoLnP", "uri": "/contracts/jyCPZUGoLnP#program-ip", "label": "Master Collaboration Agreement (Prothena Corp PLC)", "score": 29.6242294312, "published": true}, {"hash": "8T8ysQBgaFY", "uri": "/contracts/8T8ysQBgaFY#program-ip", "label": "Master Collaboration Agreement (Prothena Corp PLC)", "score": 29.3504447937, "published": true}], "hash": "eee964bd0f0c986398e6e5688c5da079", "id": 3}, {"snippet": "means know-how, knowledge, experience, inventions, processes, technical information, trade secrets, formulas, protocols, data and results (and any patents and patent applications claiming any of the foregoing), arising from or acquired specifically in the course of the development activities covered by this Agreement that relate specifically to the Licensed Product within the Field of Use.", "size": 6, "snippet_links": [{"key": "technical-information", "type": "definition", "offset": [62, 83]}, {"key": "trade-secrets", "type": "definition", "offset": [85, 98]}, {"key": "data-and-results", "type": "clause", "offset": [121, 137]}, {"key": "patents-and-patent-applications", "type": "definition", "offset": [147, 178]}, {"key": "the-foregoing", "type": "definition", "offset": [195, 208]}, {"key": "in-the-course-of", "type": "definition", "offset": [249, 265]}, {"key": "covered-by-this-agreement", "type": "clause", "offset": [293, 318]}, {"key": "licensed-product", "type": "clause", "offset": [351, 367]}, {"key": "field-of-use", "type": "definition", "offset": [379, 391]}], "samples": [{"hash": "eL67KULWaQY", "uri": "/contracts/eL67KULWaQY#program-ip", "label": "Research and Development (Innovative Drug Delivery Systems Inc)", "score": 18.0, "published": true}, {"hash": "eKgheKSB8mF", "uri": "/contracts/eKgheKSB8mF#program-ip", "label": "Research and Development and Option Agreement (Innovative Drug Delivery Systems Inc)", "score": 18.0, "published": true}, {"hash": "jNsEggY3paS", "uri": "https://www.sec.gov/Archives/edgar/data/1126424/000112528202001172/b315337_ex10-6.txt", "label": "Innovative Drug Delivery Systems Inc", "score": 2.0, "published": false}], "hash": "c7e97b465fbd1294f9cead02c55835df", "id": 4}, {"snippet": "means, individually and collectively, Program Know-How and Program Patents.", "size": 5, "snippet_links": [{"key": "program-patents", "type": "definition", "offset": [59, 74]}], "samples": [{"hash": "8bFvlaEA6bk", "uri": "/contracts/8bFvlaEA6bk#program-ip", "label": "Collaboration and License Agreement (Xencor Inc)", "score": 35.1601638794, "published": true}, {"hash": "l4XpingNeaf", "uri": "/contracts/l4XpingNeaf#program-ip", "label": "Collaboration and License Agreement (Xencor Inc)", "score": 30.3497600555, "published": true}, {"hash": "l1kRyG9EJuP", "uri": "https://investors.xencor.com/static-files/de5735ef-d519-4ae6-b184-119fd15265ed", "label": "investors.xencor.com", "score": 7.9938397408, "published": false}], "hash": "aac143acbaefaec432b396fbb8619998", "id": 5}, {"snippet": "has the meaning set forth in Section 9.2.2.", "size": 5, "snippet_links": [{"key": "section-922", "type": "clause", "offset": [29, 42]}], "samples": [{"hash": "bSQ5oKQ0LWf", "uri": "/contracts/bSQ5oKQ0LWf#program-ip", "label": "Research and Collaboration Agreement (ProQR Therapeutics N.V.)", "score": 33.9746742249, "published": true}, {"hash": "b8Mb6HjAPBB", "uri": "/contracts/b8Mb6HjAPBB#program-ip", "label": "Research and Collaboration Agreement (ProQR Therapeutics N.V.)", "score": 32.6851463318, "published": true}], "hash": "5914c00d6e6e9097d80f69540acfab5a", "id": 6}, {"snippet": "means any Program Know-How and Program Patents, collectively.", "size": 4, "snippet_links": [{"key": "program-patents", "type": "definition", "offset": [31, 46]}], "samples": [{"hash": "duv8skGY24n", "uri": "/contracts/duv8skGY24n#program-ip", "label": "License, Development, and Commercialization Agreement", "score": 31.3408622742, "published": true}, {"hash": "WCEHdvhgDd", "uri": "/contracts/WCEHdvhgDd#program-ip", "label": "License, Development, and Commercialization Agreement (Anacor Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "OcahMR0T7P", "uri": "/contracts/OcahMR0T7P#program-ip", "label": "License Agreement (Novacea Inc)", "score": 21.0, "published": true}], "hash": "5ac61838b8c28c6df2fc9d42f6ea9d66", "id": 7}, {"snippet": "means any data, results (including all clinical data), improvements and inventions generated by or on behalf of Ascendis or Licensee, or the Parties jointly, in connection with the research, development, Manufacturing, or commercialization activities conducted with respect to the Licensed Product under this Agreement, and all Intellectual Property therein.", "size": 4, "snippet_links": [{"key": "clinical-data", "type": "clause", "offset": [39, 52]}, {"key": "improvements-and-inventions", "type": "clause", "offset": [55, 82]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [93, 111]}, {"key": "the-parties", "type": "clause", "offset": [137, 148]}, {"key": "in-connection-with", "type": "clause", "offset": [158, 176]}, {"key": "the-research", "type": "clause", "offset": [177, 189]}, {"key": "commercialization-activities", "type": "definition", "offset": [222, 250]}, {"key": "with-respect-to", "type": "clause", "offset": [261, 276]}, {"key": "licensed-product", "type": "clause", "offset": [281, 297]}, {"key": "this-agreement", "type": "clause", "offset": [304, 318]}, {"key": "all-intellectual-property", "type": "clause", "offset": [324, 349]}], "samples": [{"hash": "3qruouJovwt", "uri": "/contracts/3qruouJovwt#program-ip", "label": "Exclusive Licence Agreement", "score": 31.3408622742, "published": true}, {"hash": "ydHKckhj0g", "uri": "/contracts/ydHKckhj0g#program-ip", "label": "Exclusive Licence Agreement (Ascendis Pharma a/S)", "score": 28.2511978149, "published": true}, {"hash": "7zVkE6mbhR3", "uri": "/contracts/7zVkE6mbhR3#program-ip", "label": "Exclusive Licence Agreement (Ascendis Pharma a/S)", "score": 28.2511978149, "published": true}], "hash": "80783c1904959c7afb1d8597cef9161a", "id": 8}, {"snippet": "has the meaning set forth in Section 5.7(i)", "size": 4, "snippet_links": [], "samples": [{"hash": "hOc38o1xSrk", "uri": "/contracts/hOc38o1xSrk#program-ip", "label": "Asset Purchase Agreement (Macrogenics Inc)", "score": 34.1991767883, "published": true}, {"hash": "2BlVTipMYym", "uri": "/contracts/2BlVTipMYym#program-ip", "label": "Asset Purchase Agreement (Provention Bio, Inc.)", "score": 29.4654350281, "published": true}, {"hash": "bqnSgdDMovV", "uri": "/contracts/bqnSgdDMovV#program-ip", "label": "Asset Purchase Agreement (Provention Bio, Inc.)", "score": 29.4435310364, "published": true}], "hash": "3044ad79af90925b2a4ef1cdc8d16c58", "id": 9}, {"snippet": "means Joint Patents and Joint Know-How, collectively.", "size": 4, "snippet_links": [{"key": "joint-patents", "type": "clause", "offset": [6, 19]}, {"key": "joint-know", "type": "clause", "offset": [24, 34]}], "samples": [{"hash": "kxOXRjapbMc", "uri": "/contracts/kxOXRjapbMc#program-ip", "label": "License Agreement (BeiGene, Ltd.)", "score": 26.7878170013, "published": true}, {"hash": "6JhCoxgJrKD", "uri": "/contracts/6JhCoxgJrKD#program-ip", "label": "License Agreement (BeiGene, Ltd.)", "score": 26.7878170013, "published": true}, {"hash": "hRAf1wkZB4G", "uri": "/contracts/hRAf1wkZB4G#program-ip", "label": "License Agreement (BeiGene, Ltd.)", "score": 26.7056808472, "published": true}], "hash": "0dfdb8a299f640fb0d4807e0baca5426", "id": 10}], "next_curs": "ClcSUWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjMLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiITcHJvZ3JhbS1pcCMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "means the Program Know-How and the Program Patent Rights.", "title": "Program IP", "size": 116, "id": "program-ip", "examples": ["If [*****] acquires rights under any In-Licensed <strong>Program IP</strong> outside the Field, it will do so on a non-exclusive basis unless it obtains the prior written consent of [*****] for such license outside the Field to be exclusive.", "Any Party that is pursuing a license to any In-Licensed <strong>Program IP</strong> with respect to the Field under this Section 3.9 shall keep the other Party reasonably informed of the status of any negotiations relating thereto.", "Any Party that is pursuing a license to any In-Licensed <strong>Program IP</strong> with respect to the Field under this Section 3.8 shall keep the other Party reasonably informed of the status of any negotiations relating thereto.", "As between the Parties (including their respective Affiliates), Prothena will solely own and Control all Licensed <strong>Program IP</strong>.", "Oragenics agrees to execute such documents and perform such other acts as Intrexon may reasonably request to obtain, perfect and enforce its rights to the Channel-Related <strong>Program IP</strong> and the assignment thereof.", "As between the Parties (and their respective Affiliates) and any Third Party, Prothena will solely own and Control all Licensed <strong>Program IP</strong>; provided that if (a) [***] and (b) [***].", "Any determination of inventorship with respect to any Patent within the ACI IP Rights, <strong>Program IP</strong> Rights, or Genentech IP Rights shall be made in accordance with the applicable United States patent laws.", "At the reasonable written request of a Party, the other Party will in writing grant such consents and confirm that no such accounting is required to effect the foregoing regarding Joint <strong>Program IP</strong>.", "ZIOPHARM agrees to execute such documents and perform such other acts as Intrexon may reasonably request to obtain, perfect and enforce its rights to the Channel-Related <strong>Program IP</strong> and the assignment thereof.", "ACI shall require all of its employees, contractors and agents, and any Affiliates and Third Parties working on its behalf under this Agreement (and their respective employees, contractors and agents), to assign to ACI any <strong>Program IP</strong> Rights and ACI IP Rights, created, discovered, conceived or reduced to practice by such employees, contractors or agents or Affiliates or Third Parties."], "related": [["program-technology", "Program Technology", "Program Technology"], ["collaboration-ip", "Collaboration IP", "Collaboration IP"], ["joint-technology", "Joint Technology", "Joint Technology"], ["product-technology", "Product Technology", "Product Technology"], ["licensor-technology", "Licensor Technology", "Licensor Technology"]], "related_snippets": [], "updated": "2025-11-21T05:22:43+00:00"}, "json": true, "cursor": ""}}